Putnam Announces Dividend Rates for Open-End Funds
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailBOSTON--(BUSINESS WIRE)-- The Trustees of The Putnam Funds declare the following distributions today.
|
RECORD |
PAYMENT |
|||||
|
FUND NAME AND DISTRIBUTIONS |
DATE |
DATE |
||||
|
Putnam Global Income Trust – Class B Shares (PGLBX) |
||||||
| $0.0250 per share investment income | 4/24/17 | 4/28/17 | ||||
|
Putnam Global Income Trust – Class C Shares (PGGLX) |
||||||
| $0.0250 per share investment income | 4/24/17 | 4/28/17 | ||||
|
Putnam Global Income Trust – Class M Shares (PGGMX) |
||||||
| $0.0300 per share investment income | 4/24/17 | 4/28/17 | ||||
|
Putnam Global Income Trust – Class R Shares (PGBRX) |
||||||
| $0.0300 per share investment income | 4/24/17 | 4/28/17 | ||||
|
Putnam Global Income Trust – Class Y Shares (PGGYX) |
||||||
| $0.0340 per share investment income | 4/24/17 | 4/28/17 | ||||
|
Putnam Global Income Trust – Class R5 Shares (PGGDX) |
||||||
| $0.0350 per share investment income | 4/24/17 | 4/28/17 | ||||
|
Putnam Global Income Trust – Class R6 Shares (PGGEX) |
||||||
| $0.0360 per share investment income | 4/24/17 | 4/28/17 |
|
|
View source version on businesswire.com: http://www.businesswire.com/news/home/20170424006462/en/
PUTNAM SHAREHOLDERS CONTACT:
1-800-225-1581
Source: The Putnam Funds
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bitcoin News Today: BTC Defends $82K While Remittix Counts Down to Its November 24 Market Debut
- Dogecoin and NEAR Protocol Price Prediction: NEAR Rallies 10% as Remittix Battles for Buyer Attention
- Claris Biotherapeutics Releases Positive CSB-001 Clinical Proof-of-Concept Data in Limbal Stem Cell Deficiency at AAO 2026 Annual Meeting
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Putnam Investments, DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
